PURIST

Welcome to the Brand page for “PURIST”, which is offered here for Assays for the medical diagnostic, prognostic and predictive testing of tumors; diagnostic preparations for medical purposes; medical diagnostic reagents; medical diagnostic reagents and assays for testing tissue samples; biological preparations for the detection, diagnosis, subtyping and monitoring of cancer;medical testing services; medical testing for diagnostic and treatment option purposes; medical services, cell and gene therapy research; providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the diagnosis, prognosis, treatment or management of cancer; providing a website and information in the field of medical research and scientific research in the fields of tumor biology, oncology, genetic therapy research, and diagnosis and treatment of cancers; provision of health care services, providing oncological testing reports to physicians;providing medical, scientific and pharmaceutical research services; providing medical research and scientific research information in the field of oncology; providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; providing research and development services in the oncology; research and development in the field of rna expression, cancer biology; research and development services for others, research and development of assays for oncological testing and diagnostic purposes; scientific research in the field of rna expression analysis and reporting; providing laboratory research services in the field of pancreatic cancer; research and development in the fields of biomarker discovery and validation; medical and scientific research in the field of biomarker discovery in cancer patients; pharmaceutical and medical research in the field of survival outcomes and standard of care research; medical research featuring the identification and validation of cancer related biomarkers and rna expression for use in improved patient outcomes;.

Its status is currently believed to be active. Its class is unavailable. “PURIST” is believed to be currently owned by “GENECENTRIC THERAPEUTICS, INC.”